Importantly, when the antagomir cocktail was introduced simultaneously with the ISO treatment, the elevation of these heart failure markers and the reduction in the RBFox2 protein was compensated to a level comparable to the negative control (Figure 5A,B). The gene discussed is RBFOX2; the disease is heart failure.